Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Pharmaceutical Equivalents01:26

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drug Classes and Categories01:25

Drug Classes and Categories

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Creativity and Ideation in Dental Education: Sip, Stain, and Glaze.

Journal of dental education·2025
Same author

Fluvastatin Converts Human Macrophages into Foam Cells with Increased Inflammatory Response to Inactivated <i>Mycobacterium tuberculosis H37Ra</i>.

Cells·2024
Same author

Interrogating the Role of Human Rights in Remedying Global Inequities in Access to COVID-19 Vaccines.

Health and human rights·2022
Same author

How can health technology assessment support our response to public health emergencies?

Health research policy and systems·2022
Same author

What Can We Learn From Others to Develop a Regional Centre for Infectious Diseases in ASEAN? Comment on "Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks".

International journal of health policy and management·2022
Same author

StopWatch: Pilot study for an Apple Watch application for youth with ADHD.

Digital health·2021

相关实验视频

Updated: Jun 26, 2026

Optogenetic Functional MRI
06:06

Optogenetic Functional MRI

Published on: April 19, 2016

贸易,TRIPS,以及制药.

Richard D Smith1, Carlos Correa, Cecilia Oh

  • 1Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Lancet (London, England)
|January 27, 2009
PubMed
概括

关于知识产权贸易方面的协议 (TRIPS) 惠及发达国家,但不惠及发展中国家. 它强调了制药贸易和获取药物的不平等问题,需要谈判策略.

科学领域:

  • 知识产权法 知识产权法 知识产权法
  • 国际贸易法 国际贸易法
  • 制药经济学 制药经济学

背景情况:

  • 关于知识产权贸易方面的协议 (TRIPS) 建立了全球知识产权 (IP) 标准.
  • 特里普斯显著扩大了知识产权,使制药业和发达经济体受益.
  • 发展中国家质疑TRIPS的经济收益,特别是在药品贸易方面.

研究的目的:

  • 评估TRIPS是否通过增加出口为发展中国家带来经济收益.
  • 分析TRIPS和TRIPS-plus条款对制药贸易和获得药物的影响.
  • 在TRIPS框架内为卫生界确定谈判策略.

主要方法:

  • 审查药品在全球医疗保健贸易中的重要性.
  • 分析双边自由贸易协定中的TRIPS要求,影响和TRIPS-plus条款.
  • 关于专利药物的发达国家和发展中国家之间的贸易模式的检查.

主要成果:

  • 对于发展中国家来说,TRIPS并没有带来实质性的出口收益.
  • 制药贸易主要在发达国家内增加.
  • 不平等的贸易动态和TRIPS-plus条款加剧了发展中国家获得药物的问题.

更多相关视频

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan using a One-pot, Two-step Protocol
08:33

Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan using a One-pot, Two-step Protocol

Published on: September 21, 2021

相关实验视频

Last Updated: Jun 26, 2026

Optogenetic Functional MRI
06:06

Optogenetic Functional MRI

Published on: April 19, 2016

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

Published on: May 8, 2017

Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan using a One-pot, Two-step Protocol
08:33

Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan using a One-pot, Two-step Protocol

Published on: September 21, 2021

结论:

  • 发展中国家在药品出口增加方面没有从TRIPS中显著受益.
  • 尽管许多国家没有利用TRIPS的灵活性,但TRIPS-plus条款加剧了获得药物的挑战.
  • 卫生界需要探索谈判选择,以利用TRIPS有利于他们.